期刊文献+

激光显微切割/质谱联用技术在肾脏疾病诊断中的应用进展 被引量:1

Laser microdissection and mass spectrometry based proteomics in the diagnosis of kidney diseases
原文传递
导出
摘要 激光显微切割(Laser microdissection,LMD)质谱(Mass spectrometry,MS)联用技术(LMD/MS)已成功应用于肾活检组织甲醛固定石蜡包埋切片的蛋白质组学研究,提高了某些肾脏病的诊断水平,显示出较好的临床应用前景。文中就LMD/MS蛋白质组学技术的原理、方法及该技术在肾淀粉样变性、膜增殖性肾小球肾炎等肾脏疾病的发病机制及诊断分型的应用进展进行综述。 In recent years, laser microdissection followed by mass spectrometry (LMD/MS) has been successfully applied to the proteomic studies of formalin-fixed paraffin-embedded (FFPE) renal tissues. This new technique improves the diagnosis of kidney diseases and has a better potential for future clinical application. The review focuses on the use of this methodology for exploring the mechanisms, diagnosis and classification of kidney diseases including renal amyloidosis and membrane proliferative glomerulonephritis.
出处 《生物工程学报》 CAS CSCD 北大核心 2014年第7期1134-1140,共7页 Chinese Journal of Biotechnology
基金 北京协和医院青年科研基金(No.20132755) "十二五"国家科技支撑计划(Nos.2011BA110B00 2011BA110B05) 卫生公益行业科研专项基金(No.201002010) 诺和诺德协和糖尿病英才研究基金(2014年)资助~~
关键词 激光显微切割技术 甲醛固定石蜡包埋组织蛋白质组 肾淀粉样变性 膜增殖性肾小球肾炎 laser microdissection, FFPE proteomics, renal amyloidosis, membrane proliferative glomerulonephritis
  • 相关文献

参考文献28

  • 1Decramer S, Gonzalez de Peredo A, Breuil B, et al. Urine in clinical proteomics. Mol Cell Proteomics, 2008, 7(10): 1850-1862.
  • 2Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science, 1996, 274(5289): 998-1001.
  • 3Banks RE, Dunn M J, Forbes MA, et al. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings. Electrophoresis, 1999, 20(4/5): 689-700.
  • 4Xu B J, Shyr Y, Liang X, et al. Proteomic pattems and prediction of glomerulosclerosis and its mechanisms. JAm Soc Nephrol, 2005, 16(10): 2967-2975.
  • 5Ralton LD, Murray GI. The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol, 2011, 64(4): 297-302.
  • 6Craven RA, Cairns DA, Zougman A, et al. Banks RE. Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age. Proteomics Clin Appl, 2013, 7(3/4): 273-282.
  • 7Sethi S, Vrana JA, Theis JD, et al. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curt Opin Nephrol Hypertens, 2013, 10(22): 273-280.
  • 8Sethi S, Gamez JD, Vrana JA, et al. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int, 2009, 75(9): 952-960.
  • 9Sethi S, Fervenza FC, Zhang Y, et al. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int, 2012, 82(4): 465-473.
  • 10Keller A, Nesvizhskii AI, Kolker E, et al. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem, 2002, 74(20): 5383-5392.

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部